论文信息 - No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

The protective effects of pregnancy and OC[3][1] use on ovarian cancer risk may be attributable to the action of progestins on the ovarian epithelium [(1)][2] . It has been hypothesized that a PROGINS is associated with increased risk of ovarian cancer. The PROGINS polymorphism has functional

[1] A. Berchuck,et al. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States) , 2002, Cancer Causes & Control.

[2] J. Schildkraut,et al. Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. , 2002, Journal of the National Cancer Institute.

[3] O. Olopade,et al. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. , 2001, Pharmacogenetics.

[4] A. Spurdle,et al. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. , 2001, Carcinogenesis.

[5] A. Berchuck,et al. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. , 1998, British Journal of Cancer.

[6] N. Weigel,et al. A Genetic Mutation in the Progesterone Receptor (PROGINS) leads to an increased risk of non-familial breast and ovarian cancer causing inadequate control of estrogen receptor driven proliferation , 1998 .

[7] N. McKenna,et al. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. , 1995, British Journal of Cancer.